Ping An Healthcare posts 1.16 billion RMB Q1 revenue; adjusted profit rises 45.8%

Bulletin Express
04/23

Ping An Healthcare and Technology Company Limited reported continued top-line and earnings growth for the three months ended 31 March 2026, underpinned by deeper “insurance + health care” integration and expanding corporate services.

Revenue and earnings • Revenue reached 1.16 billion RMB, up 9.1% from 1.06 billion RMB a year earlier. • Net profit surged to 79.11 million RMB, a 138.4% increase. • Adjusted net profit (excluding share-based payments and FX losses) advanced 45.8% to 84.36 million RMB.

Growth catalysts • Commercial insurance enablement: Enhanced membership services and scenario-based marketing with Ping An Group supported product appeal and client acquisition. • Corporate health management: Number of paying corporate clients in the past 12 months exceeded 7,500, an expansion of nearly 89% year on year, driving higher gross merchandise value.

Ecosystem expansion • “Online” channel: AI Doctor user base grew to more than 5.6 million. • “In-hospital”: QR-code payment coverage widened to 111,000 pharmacies nationwide, facilitating offline medicine purchases for corporate health clients. • “In-home”: Users entitled to home-based senior care services exceeded 290,000. • “In-company”: Additional Workplace Clinics were opened to bolster on-site employee health services.

Technology and service quality The company strengthened its “AI + real doctors” model, achieving an approximately 95% accuracy rate for complex disease diagnosis and treatment plans on its multidisciplinary team (MDT) platform. Further AI deployment is planned across medical services and insurance-healthcare product innovation.

Status of information All figures are unaudited and derived from the Board’s preliminary review of internal data. Ping An Healthcare advised shareholders and potential investors to exercise caution when dealing in the company’s shares.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10